Our results, based on flow cytometry data, suggest a significant time-dependent upregulation in total Bad expression (Figure 7B) in PSE- and PHY-treated BC cells, with concurrent downregulation in the protein level of the inactive, phosphorylated form of Bad (Figure 7A). The gene discussed is BAD; the disease is breast cancer.